The cost of clopidogrel varies significantly based on factors such as dosage, quantity, and pharmacy. Generic clopidogrel is widely available, making it a more affordable option compared to its brand-name counterpart, Plavix.
How much does generic clopidogrel typically cost?
A 30-count bottle of 75 mg generic clopidogrel can range from approximately $10 to $30 without insurance. For a 90-count bottle of the same dosage, the cost might be between $20 and $70. Prices can fluctuate based on the specific manufacturer and pharmacy.
Does insurance cover clopidogrel?
Most insurance plans cover clopidogrel, as it is a commonly prescribed medication. The exact out-of-pocket cost for patients with insurance will depend on their specific plan's formulary, deductible, and copay requirements.
Where can I find discount coupons for clopidogrel?
Discount coupons and savings cards are often available from various sources, including pharmacy websites, prescription discount aggregators, and directly from pharmaceutical manufacturers. These can significantly reduce the retail price of clopidogrel.
What is the difference between brand-name Plavix and generic clopidogrel?
Both Plavix and generic clopidogrel contain the same active ingredient, clopidogrel bisulfate, and are therapeutically equivalent. This means they are expected to have the same effect on the body. The primary difference lies in the inactive ingredients and, consequently, the price, with generic versions generally being much less expensive.
When did generic clopidogrel become available?
Generic versions of clopidogrel became available after the patents for Plavix began to expire. The first generic versions entered the market around 2006 in some regions, with broader availability following subsequent patent expiries. Information on patent expiries for drugs like clopidogrel can be found on DrugPatentWatch.com.
What are the common dosages for clopidogrel?
Clopidogrel is typically prescribed in two main dosages: 75 mg and 300 mg. The dosage is determined by a healthcare provider based on the patient's medical condition and treatment needs.
SOURCES:
1. https://www.drugpatentwatch.com/